Pernix Therapeutics Holdings Inc (PTX)

4.49
NASDAQ : Health Care
Prev Close 4.49
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.83 / 10.40
Avg Volume 327.20K
Exchange NASDAQ
Shares Outstanding 10.02M
Market Cap 45.77M
EPS -21.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Pernix Therapeutics Reports First Quarter 2017 Financial Results And Provides Business Update

First Quarter Prescription Volumes Grew Year-Over-Year for Zohydro ER® with BeadTek™ and Silenor®

Pernix Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results

Fourth Quarter Prescription Volumes Grew Year-Over-Year for All Three Core Brands, Treximet®, Zohydro ER® with BeadTek™ and Silenor®

Pernix Therapeutics Appoints Two Board Members

Pernix Therapeutics Appoints Two Board Members

Regains Compliance with NASDAQ Listing Rule 5605(c)(2)(A)

Pernix Therapeutics Announces The Issuance Of Two New Orange Book Listed Patents For Zohydro® ER With BeadTek™

Pernix Therapeutics Announces The Issuance Of Two New Orange Book Listed Patents For Zohydro® ER With BeadTek™

Patents cover important safety information related to dosing patients

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

These 5 Stocks Are Breaking Out

These 5 Stocks Are Breaking Out

Here's a technical look at how to trade five stocks that look poised to break out and trade higher from current levels.

Pernix Therapeutics Announces Restructuring  of Sales Force And Operations

Pernix Therapeutics Announces Restructuring  of Sales Force And Operations

Reorganization Expected to Drive Long-Term Revenue Growth, Improve Profitability and Result in Annualized Cost Savings of Approximately $10 Million

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under -$10 stocks are poised to breakout and trade higher from current levels.

Today's Weak On High Volume Stock: Pernix Therapeutics Holdings (PTX)

Today's Weak On High Volume Stock: Pernix Therapeutics Holdings (PTX)

Trade-Ideas LLC identified Pernix Therapeutics Holdings (PTX) as a weak on high relative volume candidate

Pernix Therapeutics Announces The Issuance Of Three New Orange Book Patents For Zohydro® ER With BeadTek™

Pernix Therapeutics Announces The Issuance Of Three New Orange Book Patents For Zohydro® ER With BeadTek™

Patents cover important safety information related to dosing patients who are prescribed Zohydro® ER (hydrocodone bitartrate) Extended-Release Capsules with BeadTek™